# CORVIDIA THERAPEUTICS, INC. — Form D

CORVIDIA THERAPEUTICS, INC. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-01. The offering totals $60.0M, of which $60.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-05-01
- Form: D
- Accession: 0001739146-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $60.0M
- Amount sold: $60.0M
- Investors: 15
- Date of first sale: 2018-04-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-311385

## Issuer

- Name: CORVIDIA THERAPEUTICS, INC.
- CIK: 0001739146
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 35 GATEHOUSE DRIVE, WALTHAM, MA, 02451
- Phone: (781) 205-4725

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Marc de Garidel | Director | Half Moon Bay, CA |
| SYLVIE GREGOIRE | Director | Boston, MA |
| KARIM HELMY | Director | WALTHAM, MA |
| Aaron Kantoff | Director | Rockville, MD |
| Tyrell Rivers | Director | Chicago, IL |
| Graziano Seghezzi | Director | Paris, I0 |
| RAM AIYAR | Executive Officer | WALTHAM, MA |
| Marc de Garidel | Executive Officer | Half Moon Bay, CA |

## More

- [CIK 1739146 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1739146&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001739146-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.